Effect of advanced glycation end product-modified on tissue factor expression by monocytes: Role of oxidant stress and protein tyrosine kinase activation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2885-2890

  Khechai, F ^a   Ollivier, V ^a   Bridey, F ^a   Amar, M ^a   Hakim, J ^a   De Prost, D ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Glycation; Monocyte; Oxidant stress; Thrombosis; Tissue factor

Indexed keywords

ALBUMIN; PROTEIN TYROSINE KINASE;

ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GLYCATION; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031472269     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2885     Document Type: Article

References (19)

1. Yang Z, Makita Z, Horii Y, Brunelle S, Cerami A, Sehajpal P, Suthanthiran M, Vlassara H. Two novel rat liver membrane proteins that bind advanced glycosylation end products: relationship to macrophage receptor for glucose-modified proteins. J Exp Med. 1991;174:515-524.
2. Khoury J, Thomas C, Loike S, Hickman S, Cao L, Silverstein S. Macrophages adhere to glucose-modified basement membrane via their scavenger receptors. J Biol Chem. 1994;269:10197-10200.
3. Schmidt AM, Hori O, Cao R, Yan SD, Brett J, Wautier JL, Ogawa S, Kuwabara K, Matsumoto M, Stern D. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes. 1996;45:S77-S80.
4. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science. 1988;240:1546-1548.
5. Kirstein M, Aston C, Hintz R, Vlassara H. Receptor-specific induction of insulin-like growth factor-I in human monocytes by advanced glycosylation end product modified proteins. J Clin Invest. 1994;90:439-446.
6. Kirstein M, Radoff S, Stern D. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci U S A.1990;87.9010-9014.
7. Yan SD, Schmidt AM, Anderson GM, Zhang JH, Brett J, Zou YS, Pinsky D, Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem. 1994;269:98S9-9897.
8. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun. 1990;173:932-939.
9. Ruf W, Edgington TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J. 1994;8:385-390.
10. Kwaan HC. Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes. Diabetes. 1992;41:32-35.
11. Ternisien C, Ollivier V, Khechai F, Hakim J, de Prost D. Protein tyrosine kinase activation is required for LPS and PMA induction of tissue factor mRNA in human blood monocytes. Thromb Haemost. 1995;73:413-420.
12. Ternisien C, Ramani M, Ollivier V, Khechai F, Vu T, Hakim J, de Prost D. Endotoxin-induced tissue factor in human monocytes is dependent upon protein kinase-C activation. Thromb Haemost. 1993;70:800-806.
13. Bartha K, Archipoff G, Lanza F, Cazenave JP, Beretz A. Thrombin regulates tissue factor and thrombomodulin messenger RNA levels and activities in human saphenous vein endothelial cells by distinct mechanisms. J Biol Chem. 1994;268:421-429.
14. Ostermann H, van de Loo J. Factors of the hemostatic system in diabetic patients: a survey of controlled studies. Haemostasis. 1986;16:386-716.
15. Deforge LE, Fantone JC, Kenney JS, Remick DG. Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. J Clin Invest. 1992;90:2123-2129.
16. Taniguchi N, Kaneto H, Asahi M, Takahashi M, Wenyi C, Higashiyama S, Fujii J, Suzuki K, Kayanoki Y. Involvement of glycation and oxidative stress in diabetic macroangiopathy. Diabetes. 1996;45:S81-S83.
17. Bach R, Rifkin DB. Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc Natl Acad Sci U S A. 1990;87:6995-6999.
18. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med. 1989;170:1387-1407.
19. Miyata T, Hori O, Zhang JH, Yan SD, Ferran L, Lida Y, Schmidt AM. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta(2)microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest. 1996;98:1088-1094.